Related Experiment Video

Updated: Jun 23, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

Altered molecular mechanisms of diabetic foot ulcers

Robert Blakytny1, Edward B Jude

  • 1Institute of Orthopaedic Research and Biomechanics, University of Ulm, Germany.

The International Journal of Lower Extremity Wounds
|May 16, 2009
PubMed

Insights

Diabetic foot ulcers disrupt normal healing due to altered molecular factors. Understanding these changes can lead to targeted treatments, improving patient quality of life and reducing healthcare costs.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Diabetology

Background:

  • Diabetes prevalence is rising globally, increasing the incidence of diabetic foot ulcers (DFUs).
  • Normal wound healing involves complex molecular processes, often with redundant pathways.
  • In diabetes, altered expression of numerous molecular factors overwhelms these redundancies, leading to impaired healing.

Purpose of the Study:

  • To review the relationship between molecular factor expression and altered morphology in diabetic foot ulcers.
  • To explore potential molecular-level treatment strategies for diabetic foot ulcers.

Main Methods:

  • Literature review focusing on molecular changes in diabetic wound healing.
  • Analysis of how altered molecular factors impact DFU morphology.
  • Brief consideration of molecular-targeted therapies.

Main Results:

  • Diabetes significantly alters the expression of multiple molecular factors crucial for wound healing.
  • These molecular changes disrupt the normal morphological processes required for tissue repair.
  • The inherent redundancy in healing pathways is overwhelmed in diabetic conditions.

Conclusions:

  • Understanding the molecular basis of DFU pathogenesis is key to developing effective treatments.
  • Targeted molecular therapies hold promise for improving healing outcomes in diabetic foot ulcers.
  • Addressing molecular dysregulation can enhance patient quality of life and reduce treatment costs.

Related Concept Videos

Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.